Purchases and Sales Made in Q1 2024 in Esperion Therapeutics, Inc. (ESPR)
This table provides information about the institutional ownership of Esperion Therapeutics, Inc. (ESPR) during Q1 2024. The information is specifically focused on institutions that hold shares of Esperion Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Apr 29, 2024
Q1 2024
|
Principal Financial Group Inc
Des Moines, IA |
SELL
|
- |
-4.48K- 13.33% |
$9.05K - $13.5K
|
29.2K
$74.9K
|
|
|
May 09, 2024
Q1 2024
|
Kingsview Wealth Management, LLC
Grants Pass, OR |
SELL
|
- |
-6.5K- 20.63% |
$13.1K - $19.6K
|
25K
$64.2K
|
|
|
May 14, 2024
Q1 2024
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-6.82K- 29.43% |
$13.8K - $20.6K
|
16.4K
$42K
|
|
|
May 08, 2024
Q1 2024
|
Bleakley Financial Group, LLC
Fairfield, NJ |
SELL
|
- |
-8K- 32.8% |
$16.2K - $24.2K
|
16.4K
$42.1K
|
|
|
May 10, 2024
Q1 2024
|
Y Intercept (Hong Kong) LTD
|
SELL
|
- |
-9K- 33.01% |
$18.2K - $27.2K
|
18.3K
$46.9K
|
|
|
May 15, 2024
Q1 2024
|
Diametric Capital, LP
Boston, MA |
SELL
|
- |
-11.4K- 12.91% |
$23K - $34.4K
|
76.8K
$197K
|
|
|
May 15, 2024
Q1 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-16.6K- 13.71% |
$33.5K - $50.1K
|
104K
$269K
|
|
|
May 10, 2024
Q1 2024
|
Citigroup Inc
|
SELL
|
- |
-21.2K- 5.62% |
$42.9K - $64.2K
|
357K
$917K
|
|
|
May 07, 2024
Q1 2024
|
Susquehanna Portfolio Strategies, LLC
Bala Cynwyd, PA |
SELL
|
- |
-23.9K- 20.6% |
$48.4K - $72.3K
|
92.3K
$237K
|
|
|
May 15, 2024
Q1 2024
|
Boothbay Fund Management, LLC
New York, NY |
SELL
|
- |
-49.4K- 51.03% |
$99.7K - $149K
|
47.4K
$122K
|
|
|
Nov 05, 2024
Q1 2024
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-103K- 70.22% |
$209K - $312K
|
43.8K
$113K
|
|
|
May 15, 2024
Q1 2024
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-144K- 13.18% |
$291K - $434K
|
948K
$2.44M
|
|
|
May 06, 2024
Q1 2024
|
Parallel Advisors, LLC
|
SELL
|
- |
-239K- 50.0% |
$483K - $722K
|
239K
$614K
|
|
|
May 15, 2024
Q1 2024
|
Parkman Healthcare Partners LLC
Stamford, CT |
SELL
|
- |
-282K- 19.81% |
$570K - $853K
|
1.14M
$2.94M
|
|
|
May 15, 2024
Q1 2024
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
SELL
|
- |
-354K- 33.44% |
$715K - $1.07M
|
704K
$1.81M
|
|
|
May 15, 2024
Q1 2024
|
Ubs Oconnor LLC
Chicago, IL |
SELL
|
- |
-385K- 72.98% |
$777K - $1.16M
|
142K
$366K
|
|
|
May 03, 2024
Q1 2024
|
Gsa Capital Partners LLP
London, X0 |
SELL
|
- |
-679K- 60.19% |
$1.37M - $2.05M
|
449K
$1.15M
|
|
|
May 13, 2024
Q1 2024
|
Platinum Investment Management LTD
Sydney Australia 2000, C3 |
SELL
|
- |
-1.21M- 43.16% |
$2.45M - $3.66M
|
1.6M
$4.11M
|
|
|
Oct 17, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-1.69M- 50.66% |
$3.41M - $5.09M
|
1.64M
$4.22M
|
|
|
May 15, 2024
Q1 2024
|
Two Seas Capital LP
Rye, NY |
SELL
|
- |
-3.52M- 45.8% |
$7.11M - $10.6M
|
4.17M
$10.7M
|